NCT04132882View on ClinicalTrials.gov

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

AVAILABLEEXPANDED_ACCESS

Timeline

Start Date

Not specified

Conditions

Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma

Interventions

DRUG

Sodium Thiosulfate (STS)

Trial Locations (1)

Unknown

AVAILABLE

Ankara University School of Medicine, Ankara

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Fennec Pharma

UNKNOWN

lead

TRPHARM

INDUSTRY